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Objective: To quantify Diabetes Alert Dog (DAD) performance by using
owner-independent measures.
Research Design and Methods: Eight owners of accredited DADs used a FreeStyle
Libre Flash Glucose Monitoring System (FGMS). Concurrent Closed Circuit Television
(CCTV) footage was collected for between 5 and 14 days in each owner’s home or
workplace. The footage was blind-coded for dogs’ alerting behaviors. The sensitivity,
False Positive Rate and Positive Predictive Values (PPV) of dogs’ alerts to out-of-range
(OOR) episodes were calculated. Ratings for 11 attributes describing participant’s lifestyle
and compliance (taken from each dog’s instructor) and the percentage of DAD alerts
responded to by the owner as per training protocol (taken from CCTV footage) were
assessed for association with dog performance.
Results: Dogs alerted more often when their owners’ glucose levels were outside vs.
inside target range (hypoglycaemic 2.80-fold, p = 0.001; hyperglycaemic 2.29-fold,
p = 0.005). Sensitivity to hypoglycaemic episodes ranged from 33.3 to 91.7%, the
mean was 55.9%. Mean PPV for OOR episodes was 69.7%. Sensitivity and PPV were
associated with aspects of the dog and owner’s behavior, and the owner’s adherence to
training protocol.
Conclusions: Owner-independent methods support that some dogs alert to hypo- and
hyperglycaemic events accurately, but performance varies between dogs. We find that
DAD performance is affected by traits and behaviors of both the dog and owner.
Combined with existing research showing the perceived psychosocial value and reduced
critical health care needs of DAD users, this study supports the value of a DAD as part of
a diabetes care plan. It also highlights the importance of ongoing training and continued
monitoring to ensure optimal performance.
Keywords: hypoglycaemia, hyperglycaemia, diabetes, alert, canine, behavior
INTRODUCTION
There are an estimated 4.6 million people in the United Kingdom living with diabetes (1). Of
those, ∼400,000 are currently living with Type 1 diabetes, the incidence of which is increasing
by around 4% each year (2). Without extraneous insulin intervention, blood glucose levels are
susceptible to becoming too high (hyperglycaemia) or too low (hypoglycaemia). This results from
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a failure of the body to produce insulin, and people with
Type 1 diabetes must utilize exogenous insulin via regular
injections or a continuous infusion to maintain blood glucose
levels within a “prescribed target range” in order to limit the
risk of developing long term complications associated with
this condition (3). Whilst there exists clinical definitions of
hypo- and hyperglycaemia, many individuals living with Type
1 diabetes will use approximations of these values as they may
experience physiological symptoms of hypo- and hyperglycaemia
at different blood glucose levels. Each person’s “target range”
is clinician-guided and based on personal experience at certain
“low” and “high” blood glucose values, with measures inside
of this range deemed safe for that individual. Outside of this
range, corrective measures are required (1). Hypoglycaemia is
a prevalent and serious complication of diabetes. Mild episodes
can interfere with everyday functioning, while a severe episode
requires intervention from another person and, if left untreated,
can be fatal (4, 5). People with Type 1 diabetes can become
unaware of the symptoms of hypoglycaemia over time, which
has been found to increase the risk of a severe hypoglycaemic
episode six to seven-fold (6), and is associated with an increased
risk of mortality (7). Fear of hypoglycaemia causes some people
to restrict their lifestyle in efforts to reduce the likelihood of
an episode, which negatively impacts both their quality of life
and psychological well-being (8). Individuals may intentionally
“run their blood sugars high” (maintaining hyperglycaemia)
because of fear of a severe hypoglycaemic episode (9). This
practice confers various associated health risks over time, such
as cardiovascular disease, nerve, and kidney damage (10, 11).
While an array of developing technologies are available to
people with Type 1 diabetes, many are invasive, requiring either
finger-pricks or sensor insertion, and can carry considerable
financial burdens (e.g., sensor replacement) or physical
equipment (12). Diabetes Alert Dogs (DADs) potentially
offer a non-invasive method of assisting in the recognition
of an oncoming hypo- or hyperglycaemic episode by alerting
while their owner is still able to act (13), a concept that
has led to an increase in popularity over the last decade in
using DADs as a method to facilitate tightened glycemic
control (14). DADs are trained to alert their owner by
performing attention-gaining behaviors when glucose levels
deviate from their target range. Their potential benefits are
substantial, preventing patients with glycemic unawareness
experiencing dangerous glucose fluctuations, thereby improving
owners’ quality of life and potentially reducing mortality
rates (15, 16). Given the health risks associated with diabetes,
it is imperative that the efficacy and value of DADs are
objectively assessed.
There have been 22 previous studies on DADs: seven are
owner-informed case reports of untrained and trained dogs
(13, 17–22), five use in vitro laboratory testing (23–26) and the
remaining ten use owner-reported information for at least one
aspect of data collection (12, 15, 16, 27–32). AsWeber et al.’s (33)
review highlights, small sample sizes and inconsistent sampling
methods make drawing confident conclusions problematic. Prior
to this study, there have been no entirely owner-independent
assessments of in-situ DAD performance.
Rooney et al.’s (32) study of 27 DADs suggests that the
accuracy of some dogs is very high, with a median sensitivity
to hypoglycaemic episodes of 83%. This is currently the largest
single agency study, however, it relies upon owner reports of
DAD alerts and owner provided blood-test data. This could
result in undetected false negatives; when owners are unaware
that their blood glucose has fluctuated outside of their target
range and their DAD has failed to alert them (however,
this may only impact the number of mild episodes recorded
as a severe hypoglycaemic event is likely to be recognized
due to physiological effects). Therefore, reported sensitivity of
DAD alerts in studies that use point-in-time blood test results
[e.g., (12, 16)] may be artificially high, as fluctuation into
hypo- or hyperglycaemia that did not produce a noticeable
physiological effect and to which a DAD did not alert may
have been unreported. Using a monitor that records glucose
levels at regular intervals to establish periods of euglycaemia
and hypo-/hyperglycaemia is therefore integral to accurately
assess DAD alerting sensitivity rates. Furthermore, owners
may fail to accurately record false positives (alerts occurring
during in-range glucose levels), thus previously reported
positive predictive values (PPV) of dog alerts could also be
artificially high.
Two recent experimental studies overcame the issue of
potentially missing false negatives by utilizing Continuous
GlucoseMonitoring Systems (CGMS) (30, 31). CGMS are owner-
independent as they automatically record interstitial fluid glucose
levels via a sensor inserted under the skin, which facilitates a
more accuratemeasure of DAD sensitivity since all OOR episodes
are recorded. These recent studies however still rely upon owner
reports of DAD alerts. Los et al. (30) found that a cohort
of eight DADs from multiple training backgrounds performed
variably, with an average sensitivity of 36% to hypoglycaemic
events and a PPV of only 12%. However, seven of the eight
dogs sampled had been trained to alert to hyperglycaemia, yet
only alerts to hypoglycaemia were considered correct. Hence,
of the reported 88% “incorrect” alerts, it is unknown what
proportion were actually events where the dog was alerting to
hyperglycaemia. Gonder-Frederick et al. (31) collected CGMS
data, blood test readings, and owner reports of DAD alerts from
14 participants over 6 weeks, and similarly found substantial
variation in performance between dogs, with only three out of
14 dogs performing statistically above chance level. The cause of
this variability is as yet unexplored.
Whether a dog’s alert is considered “correct” will depend on
the glucose values used to determine hypo- and hyperglycaemia.
Both Los et al. (30) and Gonder-Frederick et al. (31) used
the clinical definition of glycaemic states (≤ 3.9 mmol/L:
hypoglycaemia and ≥10.0 mmol/L: hyperglycaemia) whilst
Gonder-Frederick et al. (31) also considered “more extreme”
hypoglycaemic (≤3.0 mmol/L) and hyperglycaemic states
(≥13.9–16.7 mmol/L). Many dogs are trained to respond to
their individual owner’s target glucose range (32), so testing
their accuracy using these ranges may give a fairer assessment
of efficacy, whilst considering extreme glucose levels gives
an indication of their value at preventing severe episodes
and requiring paramedic call outs. Gonder-Frederick et al.
Frontiers in Veterinary Science | www.frontiersin.org 2 March 2019 | Volume 6 | Article 91
Wilson et al. Independent Assessment of DAD Performance
(31) saw no substantive differences in accuracy to “extreme”
glucose levels as compared to the standard definitions of hypo-
and hyperglycaemia, however, no previous study has assessed
accuracy levels to owners’ individual target ranges and extreme
glucose levels.
The current study was conducted using dogs trained by
Medical Detection Dogs (MDD), the only training institution
for DADs in the United Kingdom accredited by Assistance
Dogs UK. Initial training uses in vitro samples obtained from
the dog’s prospective owner when they are in a hypoglycaemic
state, paired with a reward to shape the dog’s response to
the odor. Response behaviors, which are reinforced, include
staring, pawing, licking the owner and/or fetching the owner’s
blood testing kit (34). In vitro training continues for ∼7 weeks.
Once a dog is deemed to be consistently responding to these
samples in a variety of environments they are placed with
their prospective owner and taught to alert in response to
the client’s target glucose range. Ongoing support and regular
assessments of sensitivity and accuracy of the dog’s alerting
behavior provide information of the success of the transfer
from in vitro training to in vivo alerting. When dogs alert,
owners should confirm if they are correct using a blood test.
Only if glucose levels are confirmed as outside of their target
range should they reward their dog. During training at MDD,
dogs are presented with hypoglycaemic samples only, since
reducing the likelihood of a life-threatening hypoglycaemic
event is the primary aim. However, most dogs subsequently
develop spontaneous alerts to hyperglycaemia, which owners are
advised to reward (with a lower value reward). Once accredited,
the owner is responsible for rewarding their dog and hence
maintaining its performance, however systematic instructor
visits are carried out. Clients also provide dog alerting and
blood test data annually to allow performance to be monitored
and re-accredited annually in accordance with Assistance Dog
International guidelines.
FGMS and CGMS are currently the best devices with which
to compare DAD performance due to their objectivity and
facilitation of recording many data points over a period of time
[e.g., (30, 31)]. These are devices that use sensors beneath the skin
to sample interstitial fluid, in the case of CGMS, continually, or
for FGMS at regular intervals, displayed to the user when they
choose to scan the sensor. However, DAD behavior is shaped
using the results of finger-prick blood tests, and readings taken by
each device often differ even when taken at the same time point
(35, 36), which may impact upon measured DAD performance.
The degree of agreement between blood tests and FGMS readings
can be quantified using Clarke-Error Grids (37) and likely varies
between individuals (38, 39). Here we explore its association to
measured DAD performance.
DAD owners anecdotally report that dogs alert to oncoming
episodes before their glucose has fallen outside their target value
(32). By using a Glucose Monitoring System, which provides
estimates of the time of transition from in-range to OOR, we can
further explore evidence of pre-alerting. Furthermore, owners
report that they may reward their dog for values approximate to
their specified low or high glucose value. Here we additionally
assess the impact of a fixed vs. ± 0.5 mmol/L margin of
error for which values are considered “correct” when assessing
DAD performance.
Lastly, an understanding of factors leading to variation in
DAD accuracy is vital in order to improve performance in the
future. Rooney et al. (32) suggest that behavioral traits in dogs,
as well as owners, may contribute. In particular, each owner’s
response to alerting behavior, and the impact of following the
recommended reward regime instilled during training, is likely
to be important. This has not been possible to test directly
in previous studies due to the reliance on owner reports of
DAD alerts. Here, utilizing CCTV footage, we can for the first
time assess whether owner compliance may have an effect on
DAD performance.
The current study presents the first entirely owner-
independent assessment of in-situ DAD accuracy. We use
FGMS to record owner blood glucose levels and CCTV cameras
to assess DAD and owner behavior, to address five questions:
1) Do dogs accurately alert their owners to hypo- and
hyperglycaemic episodes as identified by interstitial
glucose monitoring?
2) Does using individual glucose target ranges, as compared to
the clinical definition of extreme hypo- and hyperglycaemia,
affect calculated alert accuracy?
3) Does variation in analysis approach alter reported rates of
DAD accuracy? Specifically, does including a 15-min window
prior the first OOR FGMS reading (which may include
evidence of pre-alerting), or including a ± 0.5 mmol/L range
around owners specified glucose target values, alter calculated
DAD performance?
4) How do clients’ FGMS values compare to blood test
results, and does the level of agreement affect their DAD’s
measured performance?
5) Are aspects of owner lifestyle, compliance and behavior
associated with dogs’ alerting accuracy?
Elsewhere we report in detail the same cohort’s objective
behaviors during pre-defined periods of owner glucose stability
or fluctuation (40). Here we report accuracy of DAD alerts and
factors that may affect it.
RESEARCH DESIGN AND METHODS
Recruitment
Individuals were approached via telephone if they had previously
expressed an interest in taking part in research, owned an
accredited DAD trained by Medical Detection Dogs, and were
above the age of 18. Of the 14 approached, nine accepted.
Participants were sent information via email detailing the study
protocol and reminding them of their right to withdraw; however
none did. One dog was subsequently found to alert their owner
using vocalizations as well as motor behaviors, and since the
project relies on silent video footage, this dog was removed from
analysis since some vocal alerts may have been missed.
Participants
Participants were seven female and one male with Type 1
diabetes, ranging from 26 to 63 years (Median = 52.2
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TABLE 1 | Information on footage collected during the study period for each
participant and each individual’s target glucose range.
Number of
cameras
installed
Total hours of
in-sight footage
collected
Low glucose
value < (mmol/L)
High glucose
value > (mmol/L)
3 130 5.0 12.0
2 42 4.0 10.0
3 87 4.5 14.0
2 81 6.0 10.0
4 60 5.0 15.0
3 101 4.7 11.0
2 116 4.0 15.0
3 77 4.5 10.0
Values above or below these parameters are considered “out-of-range” for that individual.
Each line refers to one participant. Participant numbers have been removed for anonymity.
years). Dogs were six neutered males and two spayed females.
Breeds included four Labradors, two Labrador-Golden Retriever
crosses, one Miniature Poodle and one Golden Retriever.
All pairs had been accredited between 12 and 72 months
(Median= 47.1 months).
Initial Visit
Participants were visited in their home (seven) or place of
work (one). They were instructed to continue their pre-existing
diabetes management without alteration and asked to provide
their blood test results for the duration of the study. Their target
blood glucose range was recorded (Table 1). Participants were
provided with an information sheet, consent form, video record
sheet (to indicate periods of footage not to be viewed), blood test
record sheet and FGMS instruction sheet.
Flash Glucose Monitoring System
Participants were each loaned a FreeStyle Libre Flash Glucose
Monitoring scanner (Abbott Diabetes Care, Almeda, CA) and
were assisted to insert a sensor to be worn for 14 days (after which
the sensor expires). Three participants did not complete the full
study period, two for personal reasons (after five and 10 days
respectively) and one because the sensor fell off after 13 days. A 6
× 6 cm opaque plastic square was placed over the scanner screen
to occlude glucose level results, mitigating the risk of participants
modifying their behavior in response to on-screen glucose levels.
The FGMS device logs glucose values every 15min, and stores
additional data points every time the sensor is scanned.
Cameras
Swann CCTV Systems were used, with footage stored on a Swann
Digital Video Recorder (DVR). Between two and four cameras
were mounted in the rooms in which the participant reported
spending most of their time, maximizing the time in view. Four
participants allowed footage to be taken in their bedroom during
sleeping hours to capture nocturnal alerts. Total hours of footage
collected with owner and DAD in-view ranged from 42 to 130 h
(Mean= 86.8 h) (Table 1).
Data Collation
FGMS values were uploaded at TheUniversity of Bristol using the
FreeStyle Libre software (version 1.0). Each FGMS data point was
categorized as “hypoglycaemic,” “in-range,” or “hyperglycaemic”
depending on the individual’s target range. In subsequent analysis
this procedure was repeated using the clinical definition of
“severe” hypoglycaemia (3.0 mmol/L) and hyperglycaemia (13.9
mmol/L) to categorize OOR episodes (31, 41, 42).
Video Data
For each dog, behaviors that constituted an alert were established
from their instructor (see Table 2). Behavioral coding was carried
out using The Nodulus Observer XT Version 11.5. The footage
was watched in real time and the frequency of alerts was
recorded. For each alert, the time of occurrence, owner’s response
(including whether the owner tested their blood, whether they
rewarded the dog and, if so, whether it was before or after the
blood test) and whether the dog’s alerting behavior was deemed
unambiguous or ambiguous was also recorded. Researchers were
blinded to the FGMS values when observing the footage, which
included no sound for participant privacy and to ameliorate
bias. Participant Two and Seven’s footage was second-coded to
establish inter-rater reliability.
Statistical Methods
Inter-rater Reliability
The number of video segments in which alerts were and were
not recorded by each coder were tabulated and compared using
Cohen’s Kappa.
In-range and Out-of-Range (OOR) Episodes
OOR episodes were defined by sets of consecutive interstitial
glucose readings beyond each participant’s limits for hypo- or
hyperglycaemia. The beginning and end-point of each episode
were estimated by linear interpolation between the first OOR
reading and the previous reading, and the last OOR reading and
the next reading.
Alert Rates
The total lengths of each participant’s in-range, hypo- and
hyperglycaemic episodes, and the number of alerts that occurred
within each were calculated. The rates of alerts during periods
that were OOR to those during in-range episodes were compared
using a generalized linear model with Poisson errors. Given
that euglycaemia forms continuous rather than discrete events
an appropriate denominator cannot be defined for specificity,
hence we calculated False Positive Rates (FPR) and Positive
Predictive Values (PPV) instead. The rates of alerts that occurred
during in-range periods formed the FPR. The generalized linear
models used either a log link function (Poisson data) or logit
link function (binomial data), and included a scale parameter to
account for over dispersion between dogs.
Sensitivity
Sensitivity was calculated as the proportion of OOR episodes with
at least one alert within 15min prior to the beginning of the
OOR episode and the end of the episode. Episodes where the
dog was out of sight for two or more of the automatic glucose
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TABLE 2 | Alerting behaviors shown by each dog.
Partnership
Behavior Definition 1 2 3 4 5 6 7 8
Fetch blood testing kit
or treatment in its
mouth
Dog picks up the blood testing kit or
energy drink bottle in its mouth and
approaches the owner.
X X X X X X
Stare at owner Dog shows fixed eye contact toward
owner with eyes wide open.
X X X X X
Nuzzle owner Dog pushes face into any part of the
owner’s body or clothes. Must be in
contact with owner.
X X X
Mouth owner Dog manipulates any part of owner’s body
to be held in their jaw. Must be in contact
with owner.
X X
Paw owner Dog lifts one front foot to make contact
with the owner.
X X X X X
Lick owner Dog makes contact with any part of the
owner’s body using its tongue.
X X
Jump up on owner Dog lifts both front paws, or all four paws
off the ground and makes contact with the
owner.
X X X
Shaded boxes indicate behaviors identified by the DAD’s instructor as elicited when alerting.
readings were excluded. In a supplementary analysis, alerts in
the 15min prior to the start of an OOR episode were excluded
to assess whether excluding pre-alerts impacted on performance
estimates. Exact confidence intervals were calculated for the
sensitivity of each dog. A generalized linear model with binomial
errors was used to estimate the confidence interval for sensitivity
averaged over all dogs.
Positive Predictive Value (PPV)
PPV was calculated as the proportion of observed alerts that
occurred during, or up to 15min prior to, an OOR episode.
Exact confidence intervals were calculated for each dog. A
generalized linear model with binomial errors was used to
estimate the confidence interval for PPV averaged over all
dogs. A supplementary analysis using clinical definitions of
“extreme” hypo- and hyperglycaemic events using a glucose
value of ≤3.0 mmol/L for hypoglycaemia and ≥13.9 mmol/L for
hyperglycaemia was carried out. Since owners reported that they
sometimes reward their dog on occasions where their glucose
value was approaching their target value (rather than using the
exact value), we repeated the analysis with a ± 0.5 mmol/L
margin of error.
Clarke Error Grids
Interstitial glucose vs. blood glucose were plotted for each
partnership using the FGMS reading recorded closest in time
to each blood sample and Clarke Error Grids were constructed
(37). Results in zones A and B are considered clinically acceptable
[(35) c.f. (43)]. The FreeStyle Libre system is reported to have an
accuracy of 99.7% of data points within zones A and B (35).
Instructor Ratings
The individual who had trained each DAD partnership was
provided with a questionnaire rating 11 attributes taken
from Rooney et al. (32) where instructor interviews were used
to identify factors deemed important to the training process.
They were: Busyness of the Household, Severity of Client’s
Diabetes, Speed of Client’s Glucose Drops, Client’s Willingness to
Reward the Alerts, Client’s Ability to Recognize the Dog’s Alerts,
Client’s Confidence in the Dog’s Ability, Consistency of Client’s
Behaviour Towards Dog, Client’s Level of Communication with
Instructor, Dog’s Motivation and Enjoyment of the Task, Strength
of Dog’s Alert, Dog’s Willingness to Try New Behaviours and
“Get it Wrong.” All of these attributes were rated 1 (Very
low) to 10 (Very high). In addition, time since accreditation
(months); Number of people in household; and Children in the
household (Yes/No) were collected. Generalized linear models
with binomial errors were used to assess the value of these scores
as predictors of sensitivity and PPV. The percentage of alerts
followed by a blood test, the percentage of alerts ignored by owner
(as taken from the CCTV footage), and the percentage of FGMS
results in zones A and Bwere also assessed as potential predictors.
Across all analyses, response alerts (those that occur
immediately after the owner conducts a blood test) and
ambiguous alerts were excluded. SAS V9.4 was used for all
statistical analyses.
RESULTS
There was a strong agreement between the two observers’
judgment for Participant Two (K = 0.85, 95% CI, 0.73, 0.97,
p < 0.0001) and a moderate agreement for Participant Seven
(K = 0.70, 95% CI, 0.59, 0.82, p < 0.0001) (44).
Do dogs accurately alert their owners to both low and high
glucose episodes?
All dogs alerted more frequently during hypoglycaemic
episodes than during in-range episodes, on average by a factor of
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FIGURE 1 | (A) Sensitivity for hypoglycaemic (left) and (B) hyperglycaemic episodes (middle) defined by each participant’s own target range. (C) PPV for OOR
episodes defined by each participant’s target range (right). N = number of episodes, r = episodes with at least one alert during the episode or in the 15min
preceding it.
2.80 (95% CI 1.67, 4.68; p < 0.001). Six of the eight dogs alerted
more frequently during hyperglycaemic episodes, on average by a
factor of 2.29 (95% CI 1.29, 4.05; p = 0.005). Overall relative rate
of alerts occurring during in-range periods (False Positive Rate)
was 0.19 per hour.
Sensitivity
Ninety hypoglycaemic episodes and 63 hyperglycaemic episodes
were identified in the eight participants, defined by their
individual target ranges. Sensitivity to hypoglycaemic episodes
overall was 55.9% (95% CI 40.8, 67.4) with individual dogs
ranging from 33.3 to 91.7% (Figure 1A). When using the
definition of severe hypoglycaemia (3 mmol/L), the mean
sensitivity was similar: 54.2% overall (95% CI 37.6, 70.0).
Sensitivity to hyperglycaemic episodes was 36.5% (95% CI 29.3,
44.4) (Figure 1B).
When alerts in the 15-min period prior to an OOR episode
were considered “incorrect” (excluded), sensitivity was reduced
from 55.9 to 51.1% for hypoglycaemic episodes (95% CI 39.3,
62.8) and reduced from 36.5 to 31.7% for hyperglycaemic
episodes (95% CI 26.9, 37.0) (Figure 2).
Positive Predictive Value
PPV using each participant’s own target range was 69.7% overall
(95% CI 60.3, 76.5) (Figure 1C). Using the definition of more
extreme hypoglycaemia and hyperglycaemia, PPV was 50.4%
overall (95% CI 39.4, 61.3). When OOR episodes included a ±
0.5 mmol/Lmargin of error, PPV to OOR episodes became 75.3%
(95% CI 67.0, 82.1).
FIGURE 2 | Individual dog’s sensitivity to highs (hyperglycaemia) and lows
(hypoglycaemia), and, when considering only those alerts once the owner is
OOR, and when also including alerts 15min prior to the first OOR recording.
When two circles (one closed and one open) have the same dog number, this
indicates a change in sensitivity when alerts in the processing 15min are
considered correct. Lines indicate the population mean (when including the
preceding 15min).
FGMS and Blood Test Accuracy
Clarke Error grids show that the percentage of readings in zones
A and B ranged from 83.64 to 100% (Figure 3). Agreement levels
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FIGURE 3 | Clarke Error grids for each participant, comparing FreeStyle Libre FGMS with blood test results (% is percentage of data in zones A or B. Red crosses are
data points outside these zones).
between devices were not significantly associated with measured
DAD performance (Figure 4).
Owner Response to DAD alerts
Participant Two and Five showed a 100% adherence to training
protocol by appropriately responding to all their DAD’s alerts.
Five of the eight participants ignored alerts on at least one
occasion. Two of the eight participants rewarded their DAD prior
to testing blood glucose levels on at least one occasion (Table 3).
Instructor Ratings
Sensitivity tended to be higher in partnerships with higher scores
for Client’s Confidence in the Dog’s Ability, Dog’s Motivation and
Enjoyment of the Task, Strength of Dog’s Alert and a higher
observed percentage of alerts followed by a blood test (Figure 4).
Sensitivity tended to be lower if the observed percentage of alerts
ignored was higher (Figure 4).
PPV tended to be higher in partnerships with a high score for
Client’s Confidence in the Dog’s Ability (Figure 4). A longer length
of time since accreditation was associated with lower scores for
both sensitivity and PPV.
DISCUSSION
This study is the first to demonstrate, using objective measures
in-situ, that dogs detect episodes of both low and high blood
glucose levels. The cohort showed alerts 2.80-fold more often
in hypoglycaemic episodes and 2.29-fold in hyperglycaemic
episodes compared to when their owner was in-range. Some
dogs performed with very high levels of sensitivity and PPV,
however substantial variation was seen despite all dogs having
been trained by the same institution and following the same
protocol for accreditation.
Using CCTV footage and FGMS we found an overall
sensitivity to hypoglycaemia of 55.9%, and to hyperglycaemia
of 36.4%. PPV (proportion of alerts that were correct) averaged
69.7%. Some dogs were performing with great sensitivity
(maximum of 91.7%, Dog Five) and high PPV (maximum of
87.5%, Dog Four). Sensitivity to hyperglycemia was generally
lower than that to hypoglycaemia, as would be expected
given that dogs are formally trained on hypoglycemic scent
only. However, all eight dogs alerted to some hyperglycaemic
episodes, with one dog (Dog Two) showing higher sensitivity
to hyperglycaemia than to hypoglycaemia. This supports
Rooney et al.’s (16) finding that DADs not only can prevent
dangerous hypoglycaemic episodes but can also facilitate tighter
glycemic control. Measuring intervention effectiveness in terms
of hypoglycaemia only [e.g., (30)] has limited value, as a
person who is experiencing fewer hypoglycaemic events may
be doing so because they are maintaining their glucose
levels above target range (9), a practice that confers well-
documented health risks (45, 46). Given that dogs are shown
to be alerting to hyperglycaemia, categorizing any alerts
that occurred outside of hypoglycaemia as “incorrect” would
clearly lead to a misleading measure of performance. Our
results highlight the importance of considering hyperglycaemic
episodes and longer-term HbA1c levels in future when assessing
DAD effectiveness.
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FIGURE 4 | Odds ratios (95% confidence intervals) for potential predictor of sensitivity (to OOR episodes) and positive predictive value. Ratios are for a unit increase in
score except for months since accreditation (per year), and % of alerts followed by blood test and percentage of alerts ignored (per 10 percentage point increase).
When performance was calculated using clinical set points
for extreme hypoglycaemia (rather than individual ranges) the
cohort sensitivity was reduced slightly to 54.2% whereas the PPV
to out-of-range episodes reduced from 69.7 to 50.4%. The use
of clinical set points has been advocated in previous studies
[e.g. (30, 31)] but may not reflect the glucose levels to which
the dogs have been trained to respond. Therefore, definitions of
hypo- and hyperglycaemia should be considered in future studies
assessing DAD performance, especially if the specifications of the
dogs’ training values are at odds with the values imposed for
performance analysis.
Our findings suggest that pre-alerting is perhaps not as
common as DAD owners report, but that it does occur, as
we find three dogs showing greater sensitivity to lows, and
three dogs showing greater sensitivity to highs when we include
a 15-min window prior to the first OOR recording. As a
cohort, when alerts 15min prior to the first OOR glucose value
are considered incorrect, sensitivity to hypoglycaemic episodes
decreases from 55.9 to 51.5%, and hyperglycaemia from 37.3 to
32.9%. Furthermore, when including a ± 0.5 mmol/L margin
for the definition of an OOR episode, PPV increases from
69.7 to 76.5%. This suggests that imposing a precise cut-off
glucose level may not best represent the DAD’s function in
alerting to transitioning glucose levels. These comparisons allow
us to understand further the effect of methodology on reported
performance values and should be considered in future DAD
assessment studies.
It is important to consider that no glucose monitoring device
will provide identical results to finger-prick blood tests (47). Only
two participants reached the Abbott FreeStyle Libre reported
99.7% of readings in zones A and B (35). The FGMS used in
this study logs glucose data every 15min, meaning that readings
were compared to the closest temporally to the time of the blood
test, whichmay have affected agreement levels. The agreement for
participants Four and Eight is notably below the accepted levels
(Figure 3). The relative agreement was however not associated
with measured performance of the dogs (Figure 4). Objective
studies using a CGMS system that provides a continual glucose
trace would be optimal and are still required.
We saw a number of attributes of the partnership that were
associated with better performance, which supports Rooney
et al.’s (32) findings. Increased sensitivity was linked to Client’s
Confidence in the Dog’s Ability, Dog’s Motivation and Enjoyment
of the Task and Strength of Dog’s Alert. Increased PPV was
associated withClient’s Confidence in the Dog’s Ability and showed
a tendency to be higher with increased Owner’s Willingness to
Reward Alerts and Dog’s Motivation and Enjoyment of the Task
(Figure 4). It should be noted that across all analyses we included
only unambiguous alerts to ensure a conservative assessment
of DAD accuracy. However, there were some instances of
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TABLE 3 | Owner responses to DAD spontaneous alerts, and number of response alerts.
Spontaneous alerts Response alerts
Partnership Number of
spontaneous
alerts.
Percentage of
spontaneous alerts in
response to which owner
tested their blood (as per
training protocol).
Percentage of spontaneous alerts
ignored: i.e., the owner responded
with neither a blood test nor a reward.
Numbers in brackets are the
percentage of ignored alerts that
occurred within 15min of previous
alert (repeated alerts).
Percentage of spontaneous
alerts that owner gives DAD
reward without testing blood.
Number of alerts
occurring immediately
after owner carries out
routine test.
1 73 61.6 38.4 (9.6) 0 5
2 18 83.3 11.1 5.6 0
3 20 100 0 0 3
4 40 80 0 20 11
5 22 100 0 0 0
6 44 79.5 20.5 (20.5) 0 4
7 28 96.4 3.6 0 0
8 23 91.3 8.7 0 1
Training protocol states that owners should respond to a spontaneous alert only after a confirmatory blood test, unless the DAD has been rewarded for a correct alert and then repeats
the alert shortly after being rewarded (e.g., <15 min).
Green shading denotes “correct” owner response in-line with training protocol. Red denotes owner responses not recommended in training. Blue shading denotes “response alerts”
which are distinct from spontaneous alerts as they occur immediately after an owner takes a routine test and thus the alert is likely prompted by the visual cue of the owner testing
their blood.
ambiguous attention seeking behaviors that were unclear to both
coders and seemingly also to owners. This is of interest given
that the DAD’s instructor rating of Strength of Dog’s Alert was
associated with increased sensitivity and may point toward a
greater emphasis on developing non-ambiguous alerts (e.g., fetch
blood testing kit) during the training process. These findings
add to our current understanding of what makes a successful
partnership and which traits in both dog and owner should be
targeted during selection and matching, and further developed
during the training process.
Similar to Rooney et al. (32) we saw a decrease in sensitivity
and PPV in dogs that had been accredited for longer. This
suggests that whilst dogs finish their training period responding
reliably to OOR episodes, correct owner responses to alerts in
the home environment may not be maintained in all dogs. Once
placed, in some cases inconsistent rewarding may, with time,
reduce the dogs’ sensitivity and specificity to hypoglycaemic
episodes. Examination of CCTV footage showed variability in
owners’ adherence to training protocol when responding to a
DAD alert. We found that a higher percentage of alerts followed
by a blood test, and a lower percentage of ignored alerts, tended
to be associated with increased sensitivity and PPV (Figure 4).
Participants Three and Five, for example, showed high levels of
compliance by testing their blood following 100% of spontaneous
DAD alerts, and always testing prior to rewarding (Table 3).
Their dogs also showed high levels of sensitivity and PPV within
the cohort (Figure 2). In contrast, owners shown to ignore
spontaneous DAD alerts were found to have “poorer performing”
dogs (Figure 4). Lack of rewarding, as well as rewarding prior
to blood testing, are against advised protocol and could lead to
the dog become de-trained, since they inadvertently may learn
that alerting does not result in a reward. This may begin the
process of behavioral extinction, or shape the behavior such that
the DAD learns it can gain a reward regardless of the accuracy
of their response. While reinforcement training is rigorous
during the dog’s initial training it is likely that post-accreditation
owners vary in their ability to maintain consistent training whilst
concurrently managing their diabetes. Incorrect rewarding may
occur due to cognitive impairments during glucose fluctuations,
or due to owners relaxing their training protocol over time.
However, since owners who were observed following training
protocol correctly had more successful dogs, this highlights the
importance of regular monitoring and continuation training of
both dog and owner and the potential value of using CCTV
for monitoring. Given the small number of dogs sampled
however, this study should be considered as exploratory. The
substantial variation seen between these dogs suggests that
further investigation is important to fully understanding the
mechanisms underlying variation in DAD performance.
CONCLUSION
Owner-independent measures demonstrate that trained dogs can
alert their owners to both hypo- and hyperglycaemic blood
glucose levels, with variable but significant accuracy. We found
that using clinical vs. individual glycemic range values did not
have a substantial effect on the reported sensitivity rates of DAD
but may impact on calculated PPV if imposing glucose ranges to
which the dogs had not been trained to respond. DAD accuracy
was affected by aspects of data analysis, such as whether 15-min
pre-alerting periods were deemed correct or whether we included
a ± 0.5 mmol/L margin of error around glucose levels. This
indicates that methodological factors of analysis can influence
reported DAD accuracy levels and should be considered carefully
in future assessments.
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Whilst DADs clearly have the ability to detect OOR glucose
levels, their success relies not only on the quality of their
initial training, but also on post-accreditation factors such as
their placement environment and reward systems during their
working life. Our findings point toward a need for further
prospective investigation into factors predicting successful
partnerships and close monitoring of owner and dog behavior
in order to maintain performance post-accreditation. This study
supports the idea that DADs can function as an important
additional tool and component of a diabetes plan to facilitate
tightened glycemic control, and should complement developing
diabetes technology, rather than replace it. Results presented
here could inform strategies to optimize the relationship between
owners and their dogs, training programmes, and alerting
performance in the future.
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